According to Future Market Insights (FMI), the United States is poised to maintain its dominance in the North American Gene Synthesis Industry from 2023 to 2033. Fueled by the surging adoption of gene editing and synthesis procedures by pharmaceutical and diagnostic developers, the demand for gene synthesis services is on the rise in the United …